Control Production Costs
The investment required to produce cells using flask-based culture—in skills, resources and time—may become more cost-prohibitive as a product progresses through clinical trials. An automated cell culture platform, such as the Quantum system, makes it possible to eliminate numerous manual hands-on tasks and open events. This can result in a 70 percent reduction in labor.1
Reduce Process Complexity
Consistently reproducing a cell culture process may be difficult with flask-based methods, especially in large-scale production. Manual techniques can differ between operators, presenting the risk of batch-to-batch variability. There may also be a risk of operator error, failure or contamination due to the high level of hands-on attention required throughout the cell culture process. Early adoption of an automated cell culture platform, such as the Quantum system, can help reduce process complexity to produce increased oversight of your manufacturing process during scale-up or scale-out.
Reduce Repeated Validation and Process Change
An automated cell culture platform, such as the Quantum system, allows you to lock in a reproducible cell culture process early, which can reduce revalidation efforts later. Fewer revalidations and process changes can save time and money, delivering your cellular product to market with greater speed and efficiency.